CT imaging company CurveBeam revealed on Monday the receipt of the US FDA's 510(k) clearance for its LineUP Multi-extremity weight bearing CT system for launch in the orthopedic extremity imaging market.
The company said the compact system enables radiologists and orthopedic specialists to visualize three-dimensional bone detail of the lower extremities, while the patient is standing, so anatomy can be assessed while in the "weight bearing" or "load bearing" position.
In conjunction, the LineUP can perform bilateral scans of entire legs, the hand, wrist as well as elbow The LineUP system can be plugged into a standard wall outlet and has minimal shielding requirements. Radiation dose to the patient is significantly less than a conventional CT scan.
According to the company, the weight bearing CT imaging for body extremities became commercially available in 2012. The device has been added to the imaging services of numerous hospital foot & ankle sections, orthopedic clinics and podiatry offices worldwide. Its InReach system for hand, wrist and elbow received FDA clearance in 2017. Specialists extol the ability to confirm a scaphoid fracture diagnosis or distal radius fracture diagnosis at the point-of-care.
DATROWAY receives US priority review for first-line metastatic triple negative breast cancer
Lupin launches Dasatinib tablets in US market
Natera submits Signatera CDx PMA to FDA for bladder cancer use
Pharming receives FDA complete response letter for paediatric Joenja application
Trace Biosciences' IND application for nerve-specific imaging agent approved by FDA
Frontage expands early phase clinical research capabilities across US and China
MicuRx Pharmaceuticals' IND application for MRX-5 cleared by FDA
FDA approves Tenpoint Therapeutics' YUVEZZI as first dual-agent eye drop for presbyopia
Summit Therapeutics' BLA for ivonescimab in EGFR-mutated NSCLC accepted by FDA
WuXi Biologics collaborates with Sinorda Biomedicine for antibody development
Biogen's litifilimab receives FDA Breakthrough Therapy Designation for CLE
Glaukos receives FDA approval for repeat administration of iDose TR
Guerbet's contrast agent Elucirem approved by European Commission in children from birth
Spine Innovation's LOGIC Titanium Implant System receives US FDA 510(k) market approval